Comparison of ColoPrint risk classification with clinical risk in the prospective PARSC trial.

• Salazar, Ramon Early Clinical Research Unit, Institut Català d'Oncologia, L´Hospitalet-Barcelona, Spain
• Capdevila, Jaume Vall d'Hebron University Hospital, Barcelona, Spain
• Rosenberg, Robert Department of Surgery, Kantonsspital Baden, Baden, Switzerland
• Glimelius, Bengt Akademiska University Hospital, Uppsala, Sweden
• de Waard, Jan Willem Westfries Gasthuis, Hoorn, Netherlands
• Bibeau, Frederic Pathology Department, Institut du Cancer de Montpelier, Montpellier, France
• Klaase, Joost Medisch Spectrum Twente, Enschede, Netherlands
• Chang, George J. The University of Texas MD Anderson Cancer Center, Houston, TX
• Van Der Hoeven, Jacobus J. M. Medisch Centrum Alkmaar, Alkmaar, Netherlands
• Bachleitner-Hofmann, Thomas Medical University Vienna, Vienna, Austria
• Midgley, Rachel A Department of Oncology, University of Oxford, Oxford, England
• Levine, Edward Allen Wake Forest University, School of Medicine, Winston-Salem, NC
• Asano, Michio Matsuda Hospital, Hamamatsu, Japan
• Ziebermayr, Reinhard Academic Teaching Hospital, Elisabethinen, Linz, Austria
• Deck, Kenneth B. South Orange County Surgical Medical Group, Laguna Hills, CA
• Sington, Jamie Norfolk and Norwich University Hospital NHS FT, Norwich, United Kingdom
• Law, Wai Lun Queen Mary Hospital, University of Hong Kong, Hong Kong, Hong Kong
• Shbeeb, Imad Long Beach Memorial Medical Center, Long Beach, CA
• Stork, Lisette Agendia, Amsterdam, Netherlands
• Marshall, John Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC

Cancer Research

Oncology